This case series examines long-term outcomes for 2 aquaporin-4-IgG (AQP4-IgG)–positive patients with neuromyelitis optica spectrum disorder (NMOSD) who underwent autologous hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen and rituximab.
10.1001/jamanetworkopen.2025.5989
Journal article
American Medical Association (AMA)
2025-04-21T00:00:00+00:00
8
e255989 - e255989